Menu
Fechar
hrs4r
 I want to donate

The research group for descriptive epidemiology, genetics, and prevention of cancer is a multidisciplinary group that includes epidemiologists, statisticians, oncologists, radiotherapists, a physiotherapist, a dermatologist; a biologist, a nurse, and medical documentalists, biologist. The main focus of the group is cancer epidemiology (descriptive and analytical), cancer prevention, and genetics.

Main lines of research

Descriptive and analytical epidemiology of cancer.

Strategic objectives
  1. Descriptive and analytical epidemiology of cancer
  • Registering cancer based on population for the province of Girona (with national and international collaborations).
    • Incidence and populational prevalence of cancer, projections of the incidence of cancer
    • Populational survival of cancer (international collaborations: EUROCARE and CONCORD studies).
  • Study of genetic and molecular factors in the prognosis of breast cancer and haematological tumours.
  • Study of genetic and environmental risk factors in breast cancer and chronic lymphocytic leukaemia.
  1. Cancer prevention
  • Evaluation of the organized breast cancer screening program
  • Benefits and adverse effects of breast cancer detection: Method to improve the measurement of early detection results.
  • Evaluation of the interval rate of cancer and its determining factors in the early detection program of breast cancer in the Girona health region.
  • Evaluation of the timely detection program for cervical cancer.
  • Determination of the sensitivity and specificity of cervical cytology.
  • Evaluation of the effectiveness of vaccination against the human papilloma virus.
  1. Genetics (The genetic epidemiology of cancer)
  • Evaluation of the risk of developing cancer.
  • Study of genetic risk factors for cancer.
  • Genetic susceptibility to cancer.
Publications
Trama, A, Bernasconi, A, Cañete, A, Carulla, M, Daubisse-Marliac, L, Rossi, S, De Angelis, R, Sanvisens, A, Katalinic, A, Paapsi, K, Went, P, Mousavi, M, Blum, M, Eberle, A, Lamy, S, Capocaccia, R, Didonè, F, Botta, L

Incidence and survival of rare adult solid cancers in Europe (EUROCARE-6): A population-based study

EUROPEAN JOURNAL OF CANCER, 2025, 214, 115147-115147 dx.doi.org/10.1016/j.ejca.2024.115147
Mostaghim A, Minkove S, Aguilar-Company J, Ruiz-Camps I, Eremiev-Eremiev S, Dettorre GM, Fox L, Tondini C, Brunet J, Carmona-García M, Lambertini M, Bower M, Newsom-Davis T, Sharkey R, Pria AD, Rossi M, Plaja A, Salazar R, Sureda A, Prat A, Michalarea V, Van Hemelrijck M, Sita-Lumsden A, Bertuzzi A, Rimassa L, Rossi S, Rizzo G, Pedrazzoli P, Lee AJ, Murphy C, Belessiotis K, Diamantis N, Mukherjee U, Pommeret F, Stoclin A, Martinez-Vila C, Bruna R, Gaidano G, D'Avanzo F, Gennari A, Athale J, Eichacker P, Pinato DJ, Torabi-Parizi P, Cortellini A

Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2024, 139, 13-20 dx.doi.org/10.1016/j.ijid.2023.11.021
Gately L, Mesía C, Sepúlveda JM, Del Barco S, Pineda E, Gironés R, Fuster J, Hong W, Dumas M, Gill S, Navarro LM, Herrero A, Dowling A, de Las Peñas R, Vaz MA, Alonso M, Lwin Z, Harrup R, Peralta S, Long A, Perez-Segura P, Ahern E, Garate CO, Wong M, Campbell R, Cuff K, Jennens R, Gallego O, Underhill C, Martinez-Garcia M, Covela M, Cooper A, Brown S, Rosenthal M, Torres J, Collins IM, Gibbs P, Balana C

A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma (Dec, 10.1007/s11060-023-04513-1, 2023)

JOURNAL OF NEURO-ONCOLOGY, 2024, 166, 417-418 dx.doi.org/10.1007/s11060-024-04581-x
Pla H, Felip E, Obadia V, Pernas S, Viñas G, Margelí M, Fort-Culillas R, Del Barco S, Sabaté N, Fort E, Lezcano C, Cirauqui B, Quiroga V, Stradella A, Gil Gil M, Esteve A, Recalde S

Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort

CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26, 1748-1758 dx.doi.org/10.1007/s12094-024-03399-3
Bouvier, AM, Jooste, V, Lillini, R, Marcos-Gragera, R, Katalinic, A, Rossi, PG, Launoy, G, Bouvier, V, Guevara, M, Ardanaz, E, Aylward, ER, Innos, K, Barranco, MR, Sant, M

Differences in survival and recurrence of colorectal cancer by stage across population-based European registries

INTERNATIONAL JOURNAL OF CANCER, 2024, 155, 807-815 dx.doi.org/10.1002/ijc.34944
Trama, A, Botta, L, Stiller, C, Visser, O, Cañete-Nieto, A, Spycher, B, Bielska-Lasota, M, Katalinic, A, Vener, C, Innos, K, Marcos-Gragera, R, Paapsi, K, Guevara, M, Demuru, E, Mousavi, SM, Blum, M, Eberle, A, Ferrari, A, Bernasconi, A, Lasalvia, P

Survival of European adolescents and young adults diagnosed with cancer in 2010-2014

EUROPEAN JOURNAL OF CANCER, 2024, 202, 113558-113558 dx.doi.org/10.1016/j.ejca.2024.113558
Gately, L, Mesía, C, Sepúlveda, JM, del Barco, S, Pineda, E, Gironés, R, Fuster, J, Dumas, M, Gill, S, Navarro, LM, Herrero, A, Dowling, A, de las Peñas, R, Vaz, MA, Alonso, M, Lwin, Z, Harrup, R, Peralta, S, Long, A, Perez-Segura, P, Ahern, E, Garate, CO, Wong, M, Campbell, R, Cuff, K, Jennens, R, Gallego, O, Underhill, C, Martinez-Garcia, M, Covela, M, Cooper, A, Brown, S, Rosenthal, M, Torres, J, Collins, IM, Gibbs, P, Balana, C

Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)

JOURNAL OF NEURO-ONCOLOGY, 2024, 168, 299-306 dx.doi.org/10.1007/s11060-024-04668-5
Botta, L, Capocaccia, R, Bernasconi, A, Rossi, S, Galceran, J, Dal Maso, L, Lepage, C, Molinié, F, Bouvier, AM, Marcos-Gragera, R, Vener, C, Guevara, M, Murray, D, Ragusa, R, Gatta, G, Jooste, V

Estimating cure and risk of death from other causes of cancer patients: EUROCARE-6 data on head & neck, colorectal, and breast cancers

EUROPEAN JOURNAL OF CANCER, 2024, 208, 114187-114187 dx.doi.org/10.1016/j.ejca.2024.114187
Teixidor-Vilà E, Trallero J, Puigdemont M, Vidal-Vila A, Hernandez-Martínez A, Sais E, Sabaté-Ortega J, Verdura S, Menendez JA, Bosch-Barrera J, Sanvisens A, Marcos-Gragera R

Lung cancer survival trends and prognostic factors: A 26-year population-based study in Girona Province, Spain.

LUNG CANCER, 2024, 197, 107995-107995 dx.doi.org/10.1016/j.lungcan.2024.107995
Cubelos-Fernández N, Dávila-Batista V, Fernández-Villa T, Castaño-Vinyals G, Perez-Gomez B, Amiano P, Ardanaz E, Delgado Sillero I, Llorca J, Tardón GF, Alguacil J, Vanaclocha Espí M, Marcos-Gragera R, Moreno V, Aragones N, Dorronsoro A, Guevara M, Reguero Celada S, Pollan M, Kogevinas M, Martín V

Burden of postmenopausal breast cancer attributable to excess body weight: comparative study of body mass index and CUN-BAE in MCC-Spain study.

JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2024, 79, 64-71 dx.doi.org/10.1136/jech-2023-220706
Competitive projects
Descriptive epidemiology, genetics and cancer prevention

European Linkage of Initiative from Science to Action in Health

Codi oficial: 101128640 Start date:01/01/2024 Data fi: 31/12/2026 Investigador/a principal: RAFEL MARCOS GRAGERA Organisme finançador: EUROPEAN COMISSION
Transfer
Guies clíniques

- Adherence to the 2018 WCRF/AICR cancer prevention guidelines and chronic lymphocytic leukemia in the MCC-Spain study.

- A Poveda; V Martinez; C Serrano; I Sevilla; M J Lecumberri; RD de Beveridge; A Estival; D Vicente; J Rubió; J Martin-Broto J. SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016). Clinical Translational Oncology. Dec;18(12):1221-1228

- Gavin A,Rous B, Marcos-Gragera R, Middleton R, Steliarova-Foucher E, Maynadie M, Zanetti R, Visser O; European Network of Cancer Registries. “Towards optimal clinical and epidemiological registration of haematological malignancies: Guidelines for recording progressions, transformations and multiple diagnoses”. European Journal of Cancer. 2015 Jun;51(9):1109-22. doi: 10.1016/j.ejca.2014.02.008

- Luque R,Benavides M,Del Barco S,Egaña L,García J,Martínez M,Pérez P,Pineda E,Sepúlveda JM,Vieito M. SEOM clinical guideline for management of adult medulloblastoma (2020). Clin Transl Oncol. 2021. 23(5):p. 940-947. IF:3,405. (Q3).

Job offers

Team

If you are a researcher and you are interested in collaborating with any of our research groups, please fill in this form.
I am interested in
If you are a student or you want to do an internship with any of our research groups, please fill in this form.
I am interested in

About IDIBGI!

 menu